NIKKEI 225
38,787.38 -132.92 (-0.34%) HANG SENG
19,553.61 +177.11 (+0.91%) CRUDE OIL
79.84 -0.22 (-0.27%) GOLD FUTURES
2,423.30 +5.90 (+0.24%) DOW
40,003.59 +134.19 (+0.34%) Bitcoin GBP
52,120.72 -554.53 (-1.05%)
Vertex Pharmaceuticals Inc (VX1.HM)
| Previous close | 401.25 |
| Open | 404.70 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 404.70 - 404.70 |
| 52-week range | 300.00 - 407.10 |
| Volume | |
| Avg. volume | 1 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Jennifer Schneider Elected to Vertex Board of Directors
BOSTON, May 15, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Jennifer Schneider, M.D., M.S., has been elected to its Board of Directors as an independent director. Dr. Schneider has more than two decades of experience in the health care industry as a physician, scientist and health care executive. She co-founded and serves as Chief Executive Officer of Homeward Health, a company committed to rearchitecting the delivery of health and care for nearly 60 million Ame
- Business Wire
Vertex Reports First Quarter 2024 Financial Results
BOSTON, May 06, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the first quarter ended March 31, 2024, and reiterated full year 2024 financial guidance.
- Business Wire
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
LONDON, April 26, 2024--Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R.
